<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39365775</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients-March 2022-April 2023.</ArticleTitle><Pagination><StartPage>e0307235</StartPage><MedlinePgn>e0307235</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0307235</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0307235</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The epidemiology of COVID-19 has substantially changed since its emergence given the availability of effective vaccines, circulation of different viral variants, and re-infections. We aimed to develop models to predict 30-day COVID-19 hospitalization and death in the Omicron era for contemporary clinical and research applications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used comprehensive electronic health records from a national cohort of patients in the Veterans Health Administration (VHA) who tested positive for SARS-CoV-2 between March 1, 2022, and March 31, 2023. Full models incorporated 84 predictors, including demographics, comorbidities, and receipt of COVID-19 vaccinations and anti-SARS-CoV-2 treatments. Parsimonious models included 19 predictors. We created models for 30-day hospitalization or death, 30-day hospitalization, and 30-day all-cause mortality. We used the Super Learner ensemble machine learning algorithm to fit prediction models. Model performance was assessed with the area under the receiver operating characteristic curve (AUC), Brier scores, and calibration intercepts and slopes in a 20% holdout dataset.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Models were trained and tested on 198,174 patients, of whom 8% were hospitalized or died within 30 days of testing positive. AUCs for the full models ranged from 0.80 (hospitalization) to 0.91 (death). Brier scores were close to 0, with the lowest error in the mortality model (Brier score: 0.01). All three models were well calibrated with calibration intercepts &lt;0.23 and slopes &lt;1.05. Parsimonious models performed comparably to full models.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We developed prediction models that accurately estimate COVID-19 hospitalization and mortality risk following emergence of the Omicron variant and in the setting of COVID-19 vaccinations and antiviral treatments. These models may be used for risk stratification to inform COVID-19 treatment and to identify high-risk patients for inclusion in clinical trials.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bui</LastName><ForeName>David P</ForeName><Initials>DP</Initials><Identifier Source="ORCID">0000-0003-0861-0850</Identifier><AffiliationInfo><Affiliation>Veterans Affairs Portland Health Care System, Portland, Oregon, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Innovation to Improve Veteran Involvement in Care (CIVIC), Veterans Affairs Portland Healthcare System, Portland, Oregon, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bajema</LastName><ForeName>Kristina L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Veterans Affairs Portland Health Care System, Portland, Oregon, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Oregon Health &amp; Science University, Portland, Oregon, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuli</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajeevan</LastName><ForeName>Nallakkandi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowneki</LastName><ForeName>Mazhgan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9213-5134</Identifier><AffiliationInfo><Affiliation>Center of Innovation to Improve Veteran Involvement in Care (CIVIC), Veterans Affairs Portland Healthcare System, Portland, Oregon, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argraves</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hynes</LastName><ForeName>Denise M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Center of Innovation to Improve Veteran Involvement in Care (CIVIC), Veterans Affairs Portland Healthcare System, Portland, Oregon, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Management and Policy, School of Social and Behavioral Health Sciences, College of Health, Health Data and Informatics Program, Center for Quantitative Life Sciences, Oregon State University, Corvallis, Oregon, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Grant</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, District of Columbia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aslan</LastName><ForeName>Mihaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP CERC), Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, District of Columbia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ioannou</LastName><ForeName>George N</ForeName><Initials>GN</Initials><Identifier Source="ORCID">0000-0003-1796-8977</Identifier><AffiliationInfo><Affiliation>Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Divisions of Gastroenterology, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058014" MajorTopicYN="N">Veterans Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014493" MajorTopicYN="N">United States Department of Veterans Affairs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39365775</ArticleId><ArticleId IdType="pmc">PMC11451987</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0307235</ArticleId><ArticleId IdType="pii">PONE-D-23-41165</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang L, Zhang Y, Wang D, Tong X, Liu T, Zhang S, et al.. Artificial Intelligence for COVID-19: A Systematic Review. Front Med (Lausanne). 2021;8: 704256. doi: 10.3389/fmed.2021.704256</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.704256</ArticleId><ArticleId IdType="pmc">PMC8514781</ArticleId><ArticleId IdType="pubmed">34660623</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakibfar S, Nyberg F, Li H, Zhao J, Nordeng HME, Sandve GKF, et al.. Artificial intelligence-driven prediction of COVID-19-related hospitalization and death: a systematic review. Front Public Health. 2023;11: 1183725. doi: 10.3389/fpubh.2023.1183725</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1183725</ArticleId><ArticleId IdType="pmc">PMC10319067</ArticleId><ArticleId IdType="pubmed">37408750</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel KS, Geisler R, Maier D, Miljukov O, Hopff SM, Vehreschild JJ. A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of COVID-19 Prognostic Scores. Clinical Infectious Diseases. 2023; ciad618. doi: 10.1093/cid/ciad618</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad618</ArticleId><ArticleId IdType="pmc">PMC11006104</ArticleId><ArticleId IdType="pubmed">37879096</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins D, Makridis CA, Alterovitz G, Ramoni R, Clancy C. Developing and Implementing Predictive Models in a Learning Healthcare System: Traditional and Artificial Intelligence Approaches in the Veterans Health Administration. Annu Rev Biomed Data Sci. 2022;5: 393–413. doi: 10.1146/annurev-biodatasci-122220-110053</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biodatasci-122220-110053</ArticleId><ArticleId IdType="pubmed">35609894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad FB, Cisewski JA, Xu J, Anderson RN. COVID-19 Mortality Update—United States, 2022. MMWR Morb Mortal Wkly Rep. 2023;72: 493–496. doi: 10.15585/mmwr.mm7218a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7218a4</ArticleId><ArticleId IdType="pmc">PMC10168601</ArticleId><ArticleId IdType="pubmed">37141157</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajema KL, Berry K, Streja E, Rajeevan N, Li Y, Mutalik P, et al.. Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes. Ann Intern Med. 2023;176: 807–816. doi: 10.7326/M22-3565</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M22-3565</ArticleId><ArticleId IdType="pmc">PMC10243488</ArticleId><ArticleId IdType="pubmed">37276589</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al.. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. N Engl J Med. 2022;386: 1397–1408. doi: 10.1056/NEJMoa2118542</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118542</ArticleId><ArticleId IdType="pmc">PMC8908851</ArticleId><ArticleId IdType="pubmed">35172054</ArticleId></ArticleIdList></Reference><Reference><Citation>Barda N, Riesel D, Akriv A, Levy J, Finkel U, Yona G, et al.. Developing a COVID-19 mortality risk prediction model when individual-level data are not available. Nat Commun. 2020;11: 4439. doi: 10.1038/s41467-020-18297-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18297-9</ArticleId><ArticleId IdType="pmc">PMC7477233</ArticleId><ArticleId IdType="pubmed">32895375</ArticleId></ArticleIdList></Reference><Reference><Citation>Cisterna-García A, Guillén-Teruel A, Caracena M, Pérez E, Jiménez F, Francisco-Verdú FJ, et al.. A predictive model for hospitalization and survival to COVID-19 in a retrospective population-based study. Scientific Reports. 2022;12: 18126. doi: 10.1038/s41598-022-22547-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-22547-9</ArticleId><ArticleId IdType="pmc">PMC9614188</ArticleId><ArticleId IdType="pubmed">36307436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashti H, Roche EC, Bates DW, Mora S, Demler O. SARS2 simplified scores to estimate risk of hospitalization and death among patients with COVID-19. Scientific Reports. 2021;11: 4945. doi: 10.1038/s41598-021-84603-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84603-0</ArticleId><ArticleId IdType="pmc">PMC7925678</ArticleId><ArticleId IdType="pubmed">33654180</ArticleId></ArticleIdList></Reference><Reference><Citation>King JT Jr, Yoon JS, Rentsch CT, Tate JP, Park LS, Kidwai-Khan F, et al.. Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: The Veterans Health Administration COVID-19 (VACO) Index. PLOS ONE. 2020;15: e0241825. doi: 10.1371/journal.pone.0241825</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241825</ArticleId><ArticleId IdType="pmc">PMC7657526</ArticleId><ArticleId IdType="pubmed">33175863</ArticleId></ArticleIdList></Reference><Reference><Citation>Murtas R, Morici N, Cogliati C, Puoti M, Omazzi B, Bergamaschi W, et al.. Algorithm for Individual Prediction of COVID-19–Related Hospitalization Based on Symptoms: Development and Implementation Study. JMIR Public Health Surveill. 2021;7: e29504. doi: 10.2196/29504</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/29504</ArticleId><ArticleId IdType="pmc">PMC8594734</ArticleId><ArticleId IdType="pubmed">34543227</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Sun C, Tang X, Cheng C, Mombaerts L, Wang M, et al.. Development and Validation of a Prognostic Risk Score System for COVID-19 Inpatients: A Multi-Center Retrospective Study in China. Engineering (Beijing). 2022;8: 116–121. doi: 10.1016/j.eng.2020.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eng.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7695569</ArticleId><ArticleId IdType="pubmed">33282444</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerman BA, Dahabreh IJ, Cantos KV, Logan RW, Lodi S, Rentsch CT, et al.. Predicting counterfactual risks under hypothetical treatment strategies: an application to HIV. European Journal of Epidemiology. 2022;37: 367–376. doi: 10.1007/s10654-022-00855-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00855-8</ArticleId><ArticleId IdType="pmc">PMC9189026</ArticleId><ArticleId IdType="pubmed">35190946</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbaswamy A, Saria S. From development to deployment: dataset shift, causality, and shift-stable models in health AI. Biostatistics. 2020;21: 345–352. doi: 10.1093/biostatistics/kxz041</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxz041</ArticleId><ArticleId IdType="pubmed">31742354</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Cai G-Y, Fang W, Li H-Y, Wang S-Y, Chen L, et al.. Machine learning based early warning system enables accurate mortality risk prediction for COVID-19. Nature Communications. 2020;11: 5033. doi: 10.1038/s41467-020-18684-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18684-2</ArticleId><ArticleId IdType="pmc">PMC7538910</ArticleId><ArticleId IdType="pubmed">33024092</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath A, Lind T, Frece N, Wurzer H, Stadlbauer V. Validation of a simple risk stratification tool for COVID-19 mortality. Frontiers in Medicine. 2022;9. Available: https://www.frontiersin.org/articles/10.3389/fmed.2022.1016180

</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1016180</ArticleId><ArticleId IdType="pmc">PMC9592707</ArticleId><ArticleId IdType="pubmed">36304183</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, et al.. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370: m3339. doi: 10.1136/bmj.m3339</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3339</ArticleId><ArticleId IdType="pmc">PMC7116472</ArticleId><ArticleId IdType="pubmed">32907855</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodacre S, Thomas B, Sutton L, Burnsall M, Lee E, Bradburn M, et al.. Derivation and validation of a clinical severity score for acutely ill adults with suspected COVID-19: The PRIEST observational cohort study. PLOS ONE. 2021;16: e0245840. doi: 10.1371/journal.pone.0245840</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245840</ArticleId><ArticleId IdType="pmc">PMC7822515</ArticleId><ArticleId IdType="pubmed">33481930</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Laan MJ, Polley EC, Hubbard AE. Super learner. Stat Appl Genet Mol Biol. 2007;6: Article25. doi: 10.2202/1544-6115.1309</Citation><ArticleIdList><ArticleId IdType="doi">10.2202/1544-6115.1309</ArticleId><ArticleId IdType="pubmed">17910531</ArticleId></ArticleIdList></Reference><Reference><Citation>Naimi AI, Balzer LB. Stacked generalization: an introduction to super learning. European Journal of Epidemiology. 2018;33: 459–464. doi: 10.1007/s10654-018-0390-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-018-0390-z</ArticleId><ArticleId IdType="pmc">PMC6089257</ArticleId><ArticleId IdType="pubmed">29637384</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips RV, van der Laan MJ, Lee H, Gruber S. Practical considerations for specifying a super learner. International Journal of Epidemiology. 2023;52: 1276–1285. doi: 10.1093/ije/dyad023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyad023</ArticleId><ArticleId IdType="pubmed">36905602</ArticleId></ArticleIdList></Reference><Reference><Citation>Admon AJ, Wander PL, Iwashyna TJ, Ioannou GN, Boyko EJ, Hynes DM, et al.. Consensus elements for observational research on COVID-19-related long-term outcomes. Medicine. 2022;101: 8. doi: 10.1097/MD.0000000000031248</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000031248</ArticleId><ArticleId IdType="pmc">PMC9678399</ArticleId><ArticleId IdType="pubmed">36401423</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou GN, Green P, Fan VS, Dominitz JA, O’Hare AM, Backus LI, et al.. Development of COVIDVax Model to Estimate the Risk of SARS-CoV-2–Related Death Among 7.6 Million US Veterans for Use in Vaccination Prioritization. JAMA Network Open. 2021;4: e214347–e214347. doi: 10.1001/jamanetworkopen.2021.4347</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.4347</ArticleId><ArticleId IdType="pmc">PMC8025111</ArticleId><ArticleId IdType="pubmed">33822066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou GN, O’Hare AM, Berry K, Fan VS, Crothers K, Eastment MC, et al.. Trends Over Time in the Risk of Adverse Outcomes Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clin Infect Dis. 2022;74: 416–426. doi: 10.1093/cid/ciab419</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab419</ArticleId><ArticleId IdType="pmc">PMC8136056</ArticleId><ArticleId IdType="pubmed">33973000</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajouheshnia R, Peelen LM, Moons KGM, Reitsma JB, Groenwold RHH. Accounting for treatment use when validating a prognostic model: a simulation study. BMC Medical Research Methodology. 2017;17: 103. doi: 10.1186/s12874-017-0375-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0375-8</ArticleId><ArticleId IdType="pmc">PMC5513339</ArticleId><ArticleId IdType="pubmed">28709404</ArticleId></ArticleIdList></Reference><Reference><Citation>Groenwold RHH, Moons KGM, Pajouheshnia R, Altman DG, Collins GS, Debray TPA, et al.. Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings. Journal of Clinical Epidemiology. 2016;78: 90–100. doi: 10.1016/j.jclinepi.2016.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2016.03.017</ArticleId><ArticleId IdType="pubmed">27045189</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghirimoldi FM, Schmidt S, Simon RC, Wang C-P, Wang Z, Brimhall BB, et al.. Association of Socioeconomic Area Deprivation Index with Hospital Readmissions After Colon and Rectal Surgery. J Gastrointest Surg. 2021;25: 795–808. doi: 10.1007/s11605-020-04754-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-020-04754-9</ArticleId><ArticleId IdType="pmc">PMC7996389</ArticleId><ArticleId IdType="pubmed">32901424</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases. 1987;40: 373–383. doi: 10.1016/0021-9681(87)90171-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Porter B, Maynard C, Evans G, Bryson C, Sun H, et al.. Predicting Risk of Hospitalization or Death Among Patients Receiving Primary Care in the Veterans Health Administration. Medical Care. 2013;51. Available: https://journals.lww.com/lww-medicalcare/fulltext/2013/04000/predicting_risk_of_hospitalization_or_death_among.12.aspx</Citation><ArticleIdList><ArticleId IdType="pubmed">23269113</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne TF, Veigulis ZP, Arreola DM, Röösli E, Curtin CM. Automated EHR score to predict COVID-19 outcomes at US Department of Veterans Affairs. PLOS ONE. 2020;15: e0236554. doi: 10.1371/journal.pone.0236554</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236554</ArticleId><ArticleId IdType="pmc">PMC7384633</ArticleId><ArticleId IdType="pubmed">32716922</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber S, Lee H, Phillips R, Ho M, van der Laan M. Developing a Targeted Learning-Based Statistical Analysis Plan. Statistics in Biopharmaceutical Research. 2023;15: 468–475. doi: 10.1080/19466315.2022.2116104</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19466315.2022.2116104</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachary Butzin-Dozier, Yunwen Ji, Haodong Li, Coyle Jeremy, Junming (Seraphina) Shi, Rachael V. Philips, et al.. Predicting Long COVID in the National COVID Cohort Collaborative Using Super Learner. medRxiv. 2023; 2023.07.27. doi: 10.1101/2023.07.27.23293272</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.07.27.23293272</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Bennett TD, Bhatia A, Brooks IM, Deer RR, et al.. Identifying who has long COVID in the USA: a machine learning approach using N3C data. The Lancet Digital Health. 2022;4: e532–e541. doi: 10.1016/S2589-7500(22)00048-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>LeDell E, van der Laan MJ, Petersen M. AUC-Maximizing Ensembles through Metalearning. 2016;12: 203–218. doi: 10.1515/ijb-2015-0035</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/ijb-2015-0035</ArticleId><ArticleId IdType="pmc">PMC4912128</ArticleId><ArticleId IdType="pubmed">27227721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M. Building Predictive Models in R Using the caret Package. J Stat Soft. 2008;28: 1–26. doi: 10.18637/jss.v028.i05</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v028.i05</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Steyerberg EW. Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers. Stat Med. 2014;33: 517–535. doi: 10.1002/sim.5941</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5941</ArticleId><ArticleId IdType="pmc">PMC4793659</ArticleId><ArticleId IdType="pubmed">24002997</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Li W, Macheret F, Gabriel RA, Ohno-Machado L. A tutorial on calibration measurements and calibration models for clinical prediction models. Journal of the American Medical Informatics Association. 2020;27: 621–633. doi: 10.1093/jamia/ocz228</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz228</ArticleId><ArticleId IdType="pmc">PMC7075534</ArticleId><ArticleId IdType="pubmed">32106284</ArticleId></ArticleIdList></Reference><Reference><Citation>Veterans Health Administration COVID-19 (VACO) Index for COVID-19 Mortality. In: MDCalc [Internet]. [cited 3 Nov 2023]. Available: https://www.mdcalc.com/calc/10346/veterans-health-administration-covid-19-vaco-index-covid-19-mortality</Citation></Reference><Reference><Citation>Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, et al.. Discrimination and Calibration of Clinical Prediction Models: Users’ Guides to the Medical Literature. JAMA. 2017;318: 1377–1384. doi: 10.1001/jama.2017.12126</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.12126</ArticleId><ArticleId IdType="pubmed">29049590</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg SM, Lee S-I. A unified approach to interpreting model predictions. Advances in neural information processing systems. 2017;30.</Citation></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement. Ann Intern Med. 2015;162: 55–63. doi: 10.7326/M14-0697</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-0697</ArticleId><ArticleId IdType="pubmed">25560714</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences E, Education D of B and SS and, Integration B on H-S, Sciences D on E and P, Environment B on I and the C, Administration C on FSR for VH. Nature of Veterans Health Administration Facilities Management (Engineering) Tasks and Staffing. Facilities Staffing Requirements for the Veterans Health Administration-Resource Planning and Methodology for the Future. National Academies Press (US); 2019. Available: https://www.ncbi.nlm.nih.gov/books/NBK555777/</Citation><ArticleIdList><ArticleId IdType="pubmed">32293829</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlayson SG, Subbaswamy A, Singh K, Bowers J, Kupke A, Zittrain J, et al.. The Clinician and Dataset Shift in Artificial Intelligence. N Engl J Med. 2021;385: 283–286. doi: 10.1056/NEJMc2104626</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2104626</ArticleId><ArticleId IdType="pmc">PMC8665481</ArticleId><ArticleId IdType="pubmed">34260843</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. COVID Data Tracker. In: Centers for Disease Control and Prevention [Internet]. 28 Mar 2020 [cited 1 Nov 2023]. Available: https://covid.cdc.gov/covid-data-tracker/index.html#nationwide-blood-donor-seroprevalence</Citation></Reference><Reference><Citation>Yan L, Streja E, Li Y, Rajeevan N, Rowneki M, Berry K, et al.. Anti–SARS-CoV-2 Pharmacotherapies Among Nonhospitalized US Veterans, January 2022 to January 2023. JAMA Netw Open. 2023;6: e2331249. doi: 10.1001/jamanetworkopen.2023.31249</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.31249</ArticleId><ArticleId IdType="pmc">PMC10472184</ArticleId><ArticleId IdType="pubmed">37651140</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan M, Perrine CG, Kelleher J, Kanwar O, Kuwabara S, Bennett K, et al.. Notes From the Field: Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability—United States, December 23, 2021-August 28, 2022. MMWR Morb Mortal Wkly Rep. 2022;71: 1384–1385. doi: 10.15585/mmwr.mm7143a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7143a3</ArticleId><ArticleId IdType="pmc">PMC9620568</ArticleId><ArticleId IdType="pubmed">36301746</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, Bui D, Li Y, Rajeevan N, Rowneki M, Berry K, et al.. Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation. Clinical Infectious Diseases. 2024; ciae202. doi: 10.1093/cid/ciae202</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciae202</ArticleId><ArticleId IdType="pubmed">38864601</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>